DreamCIS Inc Net Assets
DreamCIS Inc net assets. Based on the latest financial reports, DreamCIS Inc (223250) has net assets worth ₩92.81 Billion KRW (≈ $62.90 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩152.85 Billion ≈ $103.58 Million USD) and total liabilities (₩60.03 Billion ≈ $40.68 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore DreamCIS Inc net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩92.81 Billion |
| % of Total Assets | 60.72% |
| Annual Growth Rate | 57.54% |
| 5-Year Change | 86.4% |
| 10-Year Change | N/A |
| Growth Volatility | 79.07 |
Net Assets of DreamCIS Inc (2017–2024)
Net assets of DreamCIS Inc from 2017 to 2024. This chart illustrates how DreamCIS Inc's net assets have evolved over time, based on quarterly financial data. See 223250 net asset quality score to measure how much of total assets are equity-financed.
Annual Net Assets for DreamCIS Inc (2017–2024)
The table below shows the annual net assets of DreamCIS Inc from 2017 to 2024. For live market cap and overall valuation, see how much is DreamCIS Inc worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩67.96 Billion ≈ $46.06 Million |
+19.37% |
| 2023-12-31 | ₩56.93 Billion ≈ $38.58 Million |
+16.29% |
| 2022-12-31 | ₩48.96 Billion ≈ $33.18 Million |
+28.90% |
| 2021-12-31 | ₩37.98 Billion ≈ $25.74 Million |
+4.17% |
| 2020-12-31 | ₩36.46 Billion ≈ $24.71 Million |
+239.20% |
| 2019-12-31 | ₩10.75 Billion ≈ $7.28 Million |
+65.23% |
| 2018-12-31 | ₩6.51 Billion ≈ $4.41 Million |
+130.61% |
| 2017-12-31 | ₩2.82 Billion ≈ $1.91 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to DreamCIS Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 6732.4% over the analyzed period, indicating profitable operations and earnings retention.
DreamCIS Inc Net Assets Breakdown (December 2024)
DreamCIS Inc net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩29.74 Billion | 43.75% |
| Common Stock | ₩11.90 Billion | 17.51% |
| Other Components | ₩26.33 Billion | 38.74% |
| Total Equity | ₩67.96 Billion | 100.00% |
DreamCIS Inc Competitors by Market Cap
The table below lists competitors of DreamCIS Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Energy Transition Minerals Ltd
AU:ETM
|
$65.32 Million |
|
MedFirst Healthcare Services lnc
TWO:4175
|
$65.34 Million |
|
Electrocore LLC
NASDAQ:ECOR
|
$65.37 Million |
|
Powertech Industrial Co Ltd
TW:3296
|
$65.37 Million |
|
TV Today Network Limited
NSE:TVTODAY
|
$65.30 Million |
|
Kron Telekomunikasyon Hizmetleri AS
IS:KRONT
|
$65.27 Million |
|
Pinar Sut Mamulleri Sanayi AS
IS:PNSUT
|
$65.26 Million |
|
Alterity Therapeutics Limited
F:PBN
|
$65.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DreamCIS Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 54,908,597,420 to 67,961,363,600, a change of 13,052,766,180 (23.8%).
- Net income of 5,280,148,700 contributed positively to equity growth.
- Share repurchases of 14,289,363,390 reduced equity.
- New share issuances of 239,313,390 increased equity.
- Other factors increased equity by 21,822,667,480.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩5.28 Billion | +7.77% |
| Share Repurchases | ₩14.29 Billion | -21.03% |
| Share Issuances | ₩239.31 Million | +0.35% |
| Other Changes | ₩21.82 Billion | +32.11% |
| Total Change | ₩- | 23.77% |
Book Value vs Market Value Analysis
This analysis compares DreamCIS Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.42x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.78x to 1.42x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩701.06 | ₩4050.00 | x |
| 2018-12-31 | ₩1616.71 | ₩4050.00 | x |
| 2019-12-31 | ₩2671.35 | ₩4050.00 | x |
| 2020-12-31 | ₩6550.66 | ₩4050.00 | x |
| 2021-12-31 | ₩1739.31 | ₩4050.00 | x |
| 2022-12-31 | ₩2124.13 | ₩4050.00 | x |
| 2023-12-31 | ₩2315.91 | ₩4050.00 | x |
| 2024-12-31 | ₩2855.60 | ₩4050.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DreamCIS Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.77%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.00%
- • Asset Turnover: 0.49x
- • Equity Multiplier: 1.74x
- Recent ROE (7.77%) is below the historical average (12.11%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -39.70% | -7.02% | 1.18x | 4.80x | ₩-1.40 Billion |
| 2018 | 52.53% | 17.80% | 1.09x | 2.70x | ₩2.77 Billion |
| 2019 | 38.62% | 18.77% | 0.88x | 2.33x | ₩3.08 Billion |
| 2020 | 13.31% | 20.66% | 0.48x | 1.33x | ₩1.21 Billion |
| 2021 | 8.50% | 12.35% | 0.46x | 1.49x | ₩-569.24 Million |
| 2022 | 9.00% | 11.33% | 0.50x | 1.59x | ₩-490.23 Million |
| 2023 | 6.81% | 7.81% | 0.54x | 1.61x | ₩-1.75 Billion |
| 2024 | 7.77% | 9.00% | 0.49x | 1.74x | ₩-1.52 Billion |
Industry Comparison
This section compares DreamCIS Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
No peer company data available for comparison.
About DreamCIS Inc
DreamCIS, Inc. operates as a clinical research organization in South Korea. It offers clinical development services; biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headqua… Read more